BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12705580)

  • 1. SELDI-TOF MS for diagnostic proteomics.
    Issaq HJ; Conrads TP; Prieto DA; Tirumalai R; Veenstra TD
    Anal Chem; 2003 Apr; 75(7):148A-155A. PubMed ID: 12705580
    [No Abstract]   [Full Text] [Related]  

  • 2. Accurate mass measurements in proteomics.
    Liu T; Belov ME; Jaitly N; Qian WJ; Smith RD
    Chem Rev; 2007 Aug; 107(8):3621-53. PubMed ID: 17649984
    [No Abstract]   [Full Text] [Related]  

  • 3. Brian Chait: master of mass spectrometry. Interview by Ruth Williams.
    Chait B
    J Cell Biol; 2008 Feb; 180(4):652-3. PubMed ID: 18299342
    [No Abstract]   [Full Text] [Related]  

  • 4. Computational and statistical analysis of protein mass spectrometry data.
    Noble WS; MacCoss MJ
    PLoS Comput Biol; 2012 Jan; 8(1):e1002296. PubMed ID: 22291580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconsidering adsorption in hemodialysis: is it just an epiphenomenon? A narrative review.
    Florens N; Guebre-Egziabher F; Juillard L
    J Nephrol; 2022 Jan; 35(1):33-41. PubMed ID: 33837932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary Protein Roles in Oral Health and as Predictors of Caries Risk.
    Laputková G; Schwartzová V; Bánovčin J; Alexovič M; Sabo J
    Open Life Sci; 2018 Jan; 13():174-200. PubMed ID: 33817083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A SELDI mass spectrometry study of experimental autoimmune encephalomyelitis: sample preparation, reproducibility, and differential protein expression patterns.
    Azzam S; Broadwater L; Li S; Freeman EJ; McDonough J; Gregory RB
    Proteome Sci; 2013 May; 11(1):19. PubMed ID: 23635033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Kamai T; Tomosugi N; Abe H; Kaji Y; Oyama T; Yoshida K
    Int J Mol Sci; 2012 Nov; 13(11):14518-32. PubMed ID: 23203078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An automated plasma protein fractionation design: high-throughput perspectives for proteomic analysis.
    Boccardi C; Rocchiccioli S; Cecchettini A; Mercatanti A; Citti L
    BMC Res Notes; 2012 Nov; 5():612. PubMed ID: 23116412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
    Kikkawa S; Sogawa K; Satoh M; Umemura H; Kodera Y; Matsushita K; Tomonaga T; Miyazaki M; Yokosuka O; Nomura F
    Int J Proteomics; 2012; 2012():108609. PubMed ID: 22888427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective enrichment and sensitive detection of peptide and protein biomarkers in human serum using polymeric reverse micelles and MALDI-MS.
    Rodthongkum N; Ramireddy R; Thayumanavan S; Richard WV
    Analyst; 2012 Feb; 137(4):1024-30. PubMed ID: 22193368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High throughput profiling of serum phosphoproteins/peptides using the SELDI-TOF-MS platform.
    Ji L; Jayachandran G; Roth JA
    Methods Mol Biol; 2012; 818():199-216. PubMed ID: 22083825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards in vitro molecular diagnostics using nanostructures.
    Kurkina T; Balasubramanian K
    Cell Mol Life Sci; 2012 Feb; 69(3):373-88. PubMed ID: 22009454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of renal allograft dysfunction with characteristic protein fingerprint by serum proteomic analysis.
    Wang M; Jin Q; Tu H; Mao Y; Yu J; Chen Y; Shou Z; He Q; Wu J; Zheng S; Chen J
    Int Urol Nephrol; 2011 Dec; 43(4):1009-17. PubMed ID: 21516471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern approaches to understanding stress and disease susceptibility: A review with special emphasis on respiratory disease.
    Aich P; Potter AA; Griebel PJ
    Int J Gen Med; 2009 Jul; 2():19-32. PubMed ID: 20360883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of gram-negative bacterial aerosol exposure using detected markers in bronchial-alveolar lavage fluid.
    Wunschel D; Webb-Robertson BJ; Frevert CW; Skerrett S; Beagley N; Willse A; Colburn H; Antolick K
    PLoS One; 2009 Sep; 4(9):e7047. PubMed ID: 19756149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of toxicoproteomics in assessing organ specific toxicity.
    Merrick BA; Witzmann FA
    EXS; 2009; 99():367-400. PubMed ID: 19157068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel technologies for the discovery and quantitation of biomarkers of toxicity.
    Collings FB; Vaidya VS
    Toxicology; 2008 Mar; 245(3):167-74. PubMed ID: 18237837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range.
    Gatlin-Bunai CL; Cazares LH; Cooke WE; Semmes OJ; Malyarenko DI
    J Proteome Res; 2007 Nov; 6(11):4517-24. PubMed ID: 17918874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of peptides and proteins affinity-bound to iron oxide nanoparticles by MALDI MS.
    Chang SY; Zheng NY; Chen CS; Chen CD; Chen YY; Wang CR
    J Am Soc Mass Spectrom; 2007 May; 18(5):910-8. PubMed ID: 17368044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.